Agoracom: Small Cap Investment - Mannkind - Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

in response to

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

BobW

posted on Mar 17, 2013 08:20PM

And one other thing will be that absorption is more variable via injection. Long term T1s often have a lot of scar tissue from all the injections.

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

seaside

Mar 17, 2013 09:45PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

wellsbro2

Mar 17, 2013 09:53PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

BobW

Mar 17, 2013 10:05PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

wellsbro2

Mar 17, 2013 10:38PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

Babaoriley

Mar 18, 2013 02:02AM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

liahall

Mar 18, 2013 05:28AM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog

liahall

Mar 18, 2013 05:39AM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog